NEW YORK(TheStreet) -- CHANGE IN RATINGS
Boeing (BA) - Get Report was downgraded at Oppenheimer to perform from outperform. Valuation call, as the stock is trading at a price-to-earnings ratio of 14, based on expected 2016 earnings, Oppenheimer said.
Dick's Sporting Goods (DKS) - Get Report was downgraded at BMO Capital to underperform from market perform. $46 price target. See uninspiring growth for the company in the near term, BMO Capital said.
Heartland Payment (HPY) was downgraded at Wells Fargo to market perform from outperform. Valuation call, Wells Fargo said.
Layne Christensen (LAYN) was upgraded at UBS to neutral. Future downside to earnings is largely reflected in the stock, UBS said. $16 price target.
Patterson Cos (PDCO) - Get Report was downgraded at UBS to neutral from buy. Greater competition in dental equipment and pressure on the P&L related to voluntary IT investments, UBS said. $46 price target.
[Read: 4 Stocks Under $10 Moving Higher]
Stock Comments / EPS Changes
Campbell Soup CPB numbers were cut at Credit Suisse. Shares are now seen reaching $41. Estimates were also reduced, given the company's new guidance, Credit Suisse said. Neutral rating.
[Read: The Stock Market Delivers for the White and Wealthy]
Campbell Soup EPS, price target were reduced at Jefferies. CPB decreased its own numbers, Jefferies said. Tough comps, sluggish consumer and less support from new innovations, Jefferies said. $39 price target and hold rating.
Cepheid (CPHD) was cut from the Best Ideas List at Wedbush. Valuation call, based on a $47 price target, Wedbush said.
Home Depot (HD) - Get Report price target, estimates were increased at UBS. The company lifted its own estimates, UBS said. Margin expansion in the third quarter, but two key trends were online growth and pro business growth, UBS said. $90 price target and buy rating.
Medtronic (MDT) - Get Report estimates, price target were increased at Leerink Swann. Estimates were raised through 2015. New products can help boost growth, Leerink Swann said. Market Perform rating and new $60 price target.
Medtronic price target, estimates were increased at Jefferies. Recovery in ICDs and progress in key pipeline programs, Jefferies said. $60 price target and hold rating.
Priceline.com (PCLN) was added to the Conviction Buy List at Goldman Sachs. The company is gaining ground in the U.S., Goldman said. Price target was also boosted to $1,500.
TJX (TJX) - Get Report price target, estimates were increased at UBS. Executed in a highly promotional environment, UBS said. Poised to be a standout in a holiday season, UBS also said. $73 price target and buy rating.
and become a fan on
This article was written by a staff member of TheStreet.